medic
followup
systemat
nasal
swab
perform
preand
posthajj
addit
sampl
obtain
perhajj
symptom
onset
ill
pilgrim
virus
identifi
use
biofir
filmarray
respiratori
multiplex
qualit
pcr
panel
result
pilgrim
includ
present
respiratori
symptom
hajj
still
symptomat
return
prehajj
perhajj
symptom
onset
posthajj
sampl
test
posit
p
acquisit
rate
rhinovirusenteroviru
coronaviru
influenza
viru
respect
although
rhinovirusenteroviru
coronaviru
influenza
clearanc
respect
return
overal
viru
carriag
proport
return
pilgrim
influenzalik
ill
never
experienc
symptom
resolv
ci
conclus
virus
like
play
role
pathogenesi
respiratori
tract
infect
hajj
point
carerapid
multiplex
pcr
assay
valuabl
diagnosi
tool
context
use
respiratori
symptom
onset
soon
hajj
pilgrimag
long
associ
enhanc
transmiss
infecti
diseas
agent
epidem
cholera
bacteri
mening
emblemat
exampl
potenti
intern
spread
lifethreaten
infect
hajj
given
intern
compon
pilgrim
origin
countri
gather
mecca
return
home
countri
recent
respiratori
tract
infect
hajj
attract
attent
medic
commun
frequenc
respiratori
symptom
among
pilgrim
consult
primari
health
care
facil
hospit
saudi
arabia
cohort
studi
conduct
popul
pilgrim
origin
differ
countri
report
substanti
proport
pilgrim
suffer
respiratori
symptom
stay
saudi
arabia
hand
numer
pcrbase
studi
demonstr
frequent
acquisit
respiratori
virus
follow
particip
hajj
fortun
sarscov
merscov
affect
hajj
pilgrim
far
howev
rhinoviru
nonmer
coronavirus
influenza
virus
commonli
isol
asymptomat
return
pilgrim
pilgrim
acut
respiratori
symptom
object
studi
evalu
nasal
carriag
respiratori
virus
travel
hajj
investig
possibl
relationship
viral
carriag
respiratori
symptom
care
clinic
followup
cohort
french
hajj
pilgrim
depart
marseil
fig
detail
procedur
studi
studi
conduct
among
french
hajj
pilgrim
travel
togeth
mecca
august
septemb
one
special
travel
agenc
marseil
pilgrim
older
year
includ
voluntari
basi
particip
ask
sign
written
consent
form
upon
inclus
particip
question
use
standard
pretravel
questionnair
includ
demograph
chronic
diseas
data
vaccin
statu
health
issu
record
medic
doctor
travel
group
pilgrim
consid
particip
suffer
rti
present
cough
andor
rhiniti
andor
sore
throat
influenza
like
ill
ili
defin
associ
cough
sore
throat
fever
individu
classifi
one
three
categori
asymptomat
experi
respiratori
symptom
entir
stay
saudi
arabia
ii
resolv
respiratori
tract
infect
rti
experienc
respiratori
symptom
includ
cough
andor
sore
throat
andor
rhiniti
andor
voic
failur
travel
recov
time
return
franc
iii
ongo
rti
ongo
respiratori
symptom
time
leav
saudi
arabia
protocol
approv
institut
review
board
juli
refer
perform
accord
good
clinic
practic
recommend
declar
helsinki
amend
particip
gave
written
inform
consent
procedur
includ
systemat
nasal
swab
day
depart
franc
prehajj
specimen
day
septemb
leav
ksa
kingdom
saudi
arabia
posthajj
specimen
previous
show
nasal
swab
sensit
pharyng
swab
detect
respiratori
virus
hajj
pilgrim
use
realtim
revers
transcriptasepolymeras
chain
reaction
method
nasal
swab
also
perform
among
symptomat
pilgrim
spontan
consult
accompani
medic
doctor
time
onset
perhajj
specimen
perhajj
sampl
collect
among
asymptomat
pilgrim
sampl
collect
use
commerci
rigid
cottontip
swab
applic
medic
wire
equip
wiltshir
uk
insert
anterior
nose
place
viral
transport
media
sigma
virocult
standard
procedur
previous
explain
pilgrim
investig
swab
store
transport
marseil
laboratori
storag
freezer
within
h
collect
preand
posthajj
sampl
perhajj
specimen
kept
return
franc
analys
carri
marseil
follow
return
thu
result
avail
stay
saudi
arabia
valid
multiplex
qualit
pcr
method
biofir
respiratori
panel
bfrp
biofir
includ
follow
viru
target
rhinoviru
enteroviru
adenoviru
human
coronaviru
human
metapneumoviru
influenza
viru
b
parainfluenza
viru
respiratori
syncyti
viru
three
bacteria
target
test
includ
bordetella
pertussi
chlamydia
pneumonia
mycoplasma
pneumonia
acquisit
pathogen
defin
absenc
given
pathogen
prehajj
sampl
presenc
pathogen
perand
posthajj
sampl
pearson
chisquar
test
fisher
exact
test
appropri
appli
analyz
categor
variabl
evalu
potenti
acquisit
respiratori
virus
saudi
arabia
use
mcnemar
test
compar
percentag
leav
franc
saudi
arabia
percentag
odd
ratio
confid
interv
ci
estim
comparison
carri
use
stata
copyright
statacorp
lp
http
wwwstatacom
p
valu
less
consid
signific
total
pilgrim
includ
departur
franc
median
age
year
interquartil
rang
male
individu
report
histori
chronic
respiratori
diseas
one
pilgrim
respiratori
symptom
leav
marseil
total
pilgrim
receiv
influenza
vaccin
past
month
report
vaccin
pneumococc
last
year
total
pilgrim
present
least
one
respiratori
symptom
stay
saudi
arabia
cough
rhiniti
sore
throat
frequent
tabl
median
time
arriv
saudi
arabia
symptom
onset
day
rang
day
major
pilgrim
onset
symptom
stay
mecca
mina
fig
twentyf
pilgrim
influenza
like
ill
pilgrim
took
antibiot
purpos
respiratori
tract
infect
symptom
base
clinic
judgment
accompani
doctor
none
hospit
fortythre
still
symptomat
time
leav
saudi
arabia
nasal
swab
obtain
pilgrim
travel
saudi
arabia
patient
symptom
onset
saudi
arabia
pilgrim
leav
saudi
arabia
franc
among
individu
underw
pair
sampl
allow
calcul
acquisit
rate
proport
pilgrim
posit
potenti
pathogen
detect
present
tabl
prehajj
sampl
posit
pathogen
found
perhajj
sampl
posthajj
sampl
p
overal
acquisit
rate
least
one
pathogen
stay
saudi
arabia
proport
pilgrim
posit
rhinovirusenteroviru
coronaviru
significantli
higher
posthajj
sampl
compar
prehajj
sampl
acquisit
rate
respect
multipl
infect
frequent
account
posit
perhajj
sampl
posit
posthajj
sampl
rhinoviru
enteroviruscoronaviru
mix
infect
common
tabl
case
posit
three
bacteria
test
among
asymptomat
pilgrim
sampl
franc
travel
posit
rhinovirusenteroviru
pilgrim
suffer
respiratori
symptom
travel
posit
rhinovirusenteroviru
among
pilgrim
sampl
symptom
onset
saudi
arabia
test
posit
least
one
viru
high
proport
rhinovirusenteroviru
coronaviru
influenza
tabl
seven
symptomat
pilgrim
ili
carriag
rate
significantli
differ
ill
pilgrim
data
shown
pilgrim
sampl
time
symptom
onset
resampl
leav
saudi
arabia
allow
proport
individu
allow
viral
transport
back
countri
calcul
mean
time
onset
symptom
test
leav
ksa
day
rang
rhinovirusenteroviru
carriag
clear
case
coronaviru
carriag
case
influenza
viru
carriag
case
major
case
still
symptomat
fig
comparison
viru
carriag
time
return
accord
presenc
respiratori
symptom
sampl
time
show
highest
proport
viru
posit
least
one
viru
symptomat
patient
compar
never
experienc
cough
resolv
differ
signific
ci
tabl
howev
carriag
least
one
viru
return
significantli
higher
patient
ongo
ili
symptom
compar
patient
without
ili
symptom
resolv
ili
symptom
ci
tabl
breakdown
viru
type
howev
show
statist
signific
variat
although
percentag
posit
higher
pilgrim
present
least
one
respiratori
symptom
ili
symptom
time
sampl
comparison
comparison
viru
carriag
patient
experienc
symptom
hajj
ongo
resolv
patient
asymptomat
time
show
signific
differ
observ
high
frequenc
respiratori
symptom
pilgrim
stay
ksa
cough
ili
signific
acquisit
viral
nasal
carriag
mostli
due
rhinoviru
enteroviru
coronaviru
corrobor
result
obtain
recent
studi
conduct
among
french
pilgrim
team
among
pilgrim
nation
epidem
curv
onset
symptom
viru
carriag
sampl
obtain
onset
symptom
suggest
earli
acquisit
respiratori
viru
initi
stay
mecca
probabl
due
interhuman
transmiss
attest
bimod
pattern
curv
period
time
crowd
condit
alharam
mosqu
ritual
individu
per
record
close
kaaba
like
play
signific
role
process
asymptomat
carriag
rhinovirusenteroviru
coronavirus
frequent
observ
test
return
pilgrim
nevertheless
overal
viral
carriag
patient
ili
return
significantli
higher
individu
without
ili
suggest
virus
play
role
pathogenesi
rti
virus
detect
almost
pilgrim
sampl
symptom
onset
reinforc
view
howev
pilgrim
still
symptomat
posthajj
sampl
time
low
proport
test
posit
onset
remain
posit
posthajj
sampl
two
week
first
symptom
result
although
base
small
number
ill
pilgrim
clearli
demonstr
sampl
time
leav
ksa
result
underestim
viral
carriag
relat
symptom
stay
major
ill
pilgrim
alreadi
clear
viral
infect
despit
persist
symptom
observ
survey
sinc
obtain
respiratori
sampl
onset
symptom
challeng
context
longitudin
cohort
survey
hajj
studi
conduct
far
base
systemat
sampl
obtain
time
return
day
onset
symptom
occur
design
evalu
viral
carriag
return
provid
use
potenti
respiratori
virus
spread
upon
return
countri
origin
assum
virus
detect
pcr
viabl
howev
less
appropri
retrospect
investig
respons
virus
respiratori
symptom
experienc
stay
saudi
arabia
given
rapid
viru
clearanc
particularli
obviou
survey
proport
influenza
viru
posit
pilgrim
screen
return
regardless
symptom
contrast
pilgrim
activ
consult
medic
investig
sampl
respiratori
symptom
onset
studi
conduct
differ
countri
aim
screen
influenza
viru
pcr
among
return
pilgrim
regardless
symptom
report
mean
influenza
carriag
rate
rang
line
result
report
similar
screen
studi
conduct
enrol
pilgrim
respiratori
symptom
return
home
countri
higher
proport
influenza
carriag
observ
rang
found
slightli
lower
proport
studi
final
studi
conduct
sick
pilgrim
seen
saudi
european
hospit
suspect
merscov
infect
therefor
suffer
sever
respiratori
symptom
percentag
confirm
influenza
infect
rang
studi
limit
first
conduct
among
small
number
pilgrim
one
season
hajj
result
extrapol
pilgrim
secondli
abl
collect
respiratori
sampl
symptom
onset
one
fourth
patient
report
suffer
respiratori
symptom
studi
period
low
proport
due
natur
recruit
sinc
sampl
onset
symptom
systemat
perform
patient
spontan
consult
accompani
doctor
earli
begin
ill
sampl
type
use
fda
clear
ce
mark
bfrp
biofir
perform
characterist
use
nasal
swab
instead
nasopharyng
swab
establish
virus
acquir
vast
major
hajj
pilgrim
soon
arriv
mecca
like
respons
respiratori
symptom
notabl
ili
viral
clearanc
rapid
point
carerapid
multiplex
pcr
assay
valuabl
diagnosi
tool
hajj
patient
use
respiratori
symptom
onset
soon
particular
allow
detect
influenza
viru
particularli
interest
practic
consequ
earli
prescript
antivir
peopl
risk
test
also
use
rulingout
merccov
infect
decid
isol
measur
lift
odd
ratio
ci
confid
interv
least
one
respiratori
symptom
cough
sore
throat
rhiniti
odd
ratio
ci
confid
interv
ili
influenzalik
ill
cough
sore
throat
fever
